Free Trial

ATI Physical Therapy (ATIP) Competitors

ATI Physical Therapy logo
$1.03 0.00 (0.00%)
As of 07/8/2025

ATIP vs. ENZ, BRTX, MGRX, SSY, BGLC, ACON, DHAC, OTRK, NIVF, and BACK

Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include Enzo Biochem (ENZ), Biorestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), Aclarion (ACON), Digital Health Acquisition (DHAC), Ontrak (OTRK), NewGenIvf Group (NIVF), and IMAC (BACK). These companies are all part of the "healthcare" industry.

ATI Physical Therapy vs. Its Competitors

Enzo Biochem (NYSE:ENZ) and ATI Physical Therapy (NYSE:ATIP) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

ATI Physical Therapy has a net margin of -7.79% compared to Enzo Biochem's net margin of -75.34%. ATI Physical Therapy's return on equity of 0.00% beat Enzo Biochem's return on equity.

Company Net Margins Return on Equity Return on Assets
Enzo Biochem-75.34% -7.96% -5.49%
ATI Physical Therapy -7.79%N/A -3.87%

36.9% of Enzo Biochem shares are held by institutional investors. Comparatively, 72.6% of ATI Physical Therapy shares are held by institutional investors. 11.4% of Enzo Biochem shares are held by insiders. Comparatively, 3.3% of ATI Physical Therapy shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Enzo Biochem has higher earnings, but lower revenue than ATI Physical Therapy.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enzo Biochem$29.09M0.59-$26.08MN/AN/A
ATI Physical Therapy$741.86M0.01-$69.79M-$19.42-0.05

Enzo Biochem has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, ATI Physical Therapy has a beta of -0.15, indicating that its share price is 115% less volatile than the S&P 500.

In the previous week, Enzo Biochem's average media sentiment score of 0.00 equaled ATI Physical Therapy'saverage media sentiment score.

Company Overall Sentiment
Enzo Biochem Neutral
ATI Physical Therapy Neutral

Summary

ATI Physical Therapy beats Enzo Biochem on 5 of the 9 factors compared between the two stocks.

Get ATI Physical Therapy News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATIP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATIP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATIP vs. The Competition

MetricATI Physical TherapyNursing & personal care facilities IndustryMedical SectorNYSE Exchange
Market Cap$4.54M$4.54M$5.51B$20.51B
Dividend YieldN/AN/A5.25%3.73%
P/E Ratio-0.06N/A28.0527.90
Price / Sales0.010.01438.1440.92
Price / Cash0.190.1937.0622.25
Price / Book-0.04N/A8.124.59
Net Income-$69.79M-$69.79M$3.16B$982.91M
7 Day Performance3.00%3.00%4.40%0.74%
1 Month Performance11.05%11.05%4.09%3.94%
1 Year Performance-81.90%-81.90%34.53%14.82%

ATI Physical Therapy Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATIP
ATI Physical Therapy
N/A$1.03
flat
N/A-80.2%$4.54M$741.86M-0.065,600Gap Down
ENZ
Enzo Biochem
N/A$0.33
-14.8%
N/A-68.8%$17.03M$29.09M0.00520Gap Down
High Trading Volume
BRTX
Biorestorative Therapies
2.7415 of 5 stars
$1.63
-2.1%
$18.00
+1,004.3%
-9.0%$12.50M$400K0.007
MGRX
Mangoceuticals
1.0665 of 5 stars
$1.51
-0.7%
N/A-98.1%$7.86M$620K0.003News Coverage
Positive News
SSY
SunLink Health Systems
1.4527 of 5 stars
$0.90
+2.6%
N/A+24.7%$6.36M$31.09M6.451,376News Coverage
BGLC
BioNexus Gene Lab
0.4237 of 5 stars
$11.14
+262.9%
N/A+33.4%$5.52M$9.51M0.0030Gap Down
High Trading Volume
ACON
Aclarion
2.2121 of 5 stars
$7.61
+1.1%
$11,758.50
+154,413.8%
-99.7%$4.38M$50K0.007Positive News
DHAC
Digital Health Acquisition
N/A$1.10
-3.5%
N/A-86.8%$3.96MN/A0.002,021News Coverage
Gap Down
OTRK
Ontrak
3.1362 of 5 stars
$0.46
-7.9%
$45.00
+9,686.9%
-86.3%$2.11M$10.85M0.00250Analyst Forecast
High Trading Volume
NIVF
NewGenIvf Group
N/A$0.99
-4.8%
N/A-99.7%$550K$5.43M0.00N/AGap Down
High Trading Volume
BACK
IMAC
N/A$0.06
+24.0%
N/A-96.2%$128K$72.05K0.00180Trending News

Related Companies and Tools


This page (NYSE:ATIP) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners